Clinical Trial Update: Test-retest Study With [18F]FBB in Cardiac Amyloidosis [Phase 1]

View source ↗

Summary

Phase 1 test-retest study of the PET tracer [18F]FBB in cardiac amyloidosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Amyloidosis

Drugs mentioned

• [18F]FBB

Snippet

Sponsor: Life Molecular Imaging GmbH | Conditions: Cardiac Amyloidosis | Phase 1 | Status: RECRUITING